Skip to main content

20-09-2017 | Melanoma | ESMO 2017 | Video

ESMO 2017: Melanoma highlights

ESMO Melanoma Faculty Coordinator Olivier Michielin discusses the CheckMate 238, COMBI-AD, and BRIM8 trials presented at the third Presidential symposium.

Read the related news stories on the CheckMate 238 and COMBI-AD trials.

Please log in to get access to this content

image credits